Newsroom
October 15, 2019
For Melissa Stockhoff, wife and mother to three small kids, life moves fast. She grew up in Idaho and made her way across the country before landing in Texas with her family. But in 2015, at the age of 33, her world came to a stop. What started out as a suspicious lump in her […]
September 17, 2019
UT Health San Antonio biochemist Patrick Sung, D.Phil., one of the world’s leading experts on BRCA1 and BRCA2 cancer biology, has just received a highly competitive National Cancer Institute (NCI) Outstanding Investigator Award. Dr. Sung is the first faculty member in UT Health San Antonio history to capture this prestigious NCI award, which is bestowed […]
September 10, 2019
The U.S. Food and Drug Administration recently approved the first new medication in nearly a decade for patients with myelofibrosis, a rare blood cancer. Ruben Mesa, M.D., FACP, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was part of the international research team that led development of […]
August 27, 2019
UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in […]
June 10, 2019
Researchers at UT Health San Antonio, in collaboration with the University of Texas at San Antonio, have developed a new class of drugs called capsazepine analogs, which bear structural similarities to capsaicin. In preclinical testing on mice, the drugs have shown promise in dramatically reducing the size of tumors. See the Express-News coverage of this […]
June 6, 2019
Pediatric oncologist and researcher Gregory Aune, M.D., Ph.D., tells the story of his favorite patient, a teenage boy some 30 years ago who was diagnosed with Hodgkin’s lymphoma.